Compare TMCI & OXSQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TMCI | OXSQ |
|---|---|---|
| Founded | 2014 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Blank Checks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 144.0M | 151.9M |
| IPO Year | 2021 | N/A |
| Metric | TMCI | OXSQ |
|---|---|---|
| Price | $1.84 | $1.74 |
| Analyst Decision | Hold | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $4.21 | N/A |
| AVG Volume (30 Days) | 617.2K | ★ 1.2M |
| Earning Date | 02-27-2026 | 02-27-2026 |
| Dividend Yield | N/A | ★ 23.20% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $218,879,000.00 | $40,142,565.00 |
| Revenue This Year | $3.30 | N/A |
| Revenue Next Year | N/A | $2.27 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 7.90 | N/A |
| 52 Week Low | $1.86 | $1.56 |
| 52 Week High | $10.30 | $2.87 |
| Indicator | TMCI | OXSQ |
|---|---|---|
| Relative Strength Index (RSI) | 28.79 | 38.78 |
| Support Level | $2.02 | $1.87 |
| Resistance Level | $2.31 | $1.93 |
| Average True Range (ATR) | 0.16 | 0.06 |
| MACD | -0.03 | -0.01 |
| Stochastic Oscillator | 7.88 | 6.25 |
Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The Company operates and manages its business as one segment, which is the business of designing, manufacturing, and marketing medical devices for physicians, surgeons, ambulatory surgery centers and hospitals.
Oxford Square Capital Corp is a closed-end, non-diversified management investment company with a focus is to seek an attractive risk-adjusted total return by investing in corporate debt securities and collateralized loan obligation (CLO) structured finance investments that own corporate debt securities. its capital is generally used by its corporate borrowers to finance organic growth, acquisitions, recapitalizations, and working capital. The group invests in various industries such as Structured Finance, IT Consulting, Business Services, Utilities, Software, Healthcare, Telecommunication Services, Plastics Manufacturing and Diversified Insurance.